Ultrasound-based procedure for uterine medical treatment

• US 20050256405A1
• Filed: 05/17/2004
• Published: 11/17/2005
• Est. Priority Date: 05/17/2004
• Status: Abandoned Application

• Current Assignee: Ethicon Endo-Surgery, Inc. (Johnson & Johnson)
• Original Assignee: Ethicon Endo-Surgery, Inc. (Johnson & Johnson)
• Inventors: Makin, Inder Raj S., Slayton, Michael H., Barthe, Peter G., Avidor, Yoav
• Application Number:
  US10/847,209
• Publication Number:
  US 20050256405A1
• Time in Patent Office: Days
• US Class Current: 600/439
• CPC Class Codes: A61B 2017/320069 for ablating tissue
• CPC Class Codes: A61B 2017/320071 with articulating means for working tip
• CPC Class Codes: A61B 2017/320094 additional movable means performing clamping operation
• CPC Class Codes: A61B 2017/320095 with sealing or cauterizing means
• CPC Class Codes: A61B 2017/4216 Operations on uterus, e.g. endometrium
• CPC Class Codes: A61B 5/489 Blood vessels
• CPC Class Codes: A61B 8/12 in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00

Abstract

A first method for ultrasound uterine medical treatment includes obtaining an end effector having an ultrasound medical-treatment transducer assembly, identifying a blood vessel which supplies blood to a portion of the uterus, and medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood from the blood vessel to the portion of the uterus. In one example, shrinkage of a uterine fibroid is accomplished through use of the end effector endoscopically inserted into the uterus. A second method for ultrasound uterine medical treatment includes endoscopically inserting the end effector into the uterus and medically treating the endometrium lining with ultrasound from the transducer assembly to ablate a desired thickness of at least a portion of the endometrium lining to substantially stop abnormal uterine bleeding from the endometrium lining.

Claims

1. A method for ultrasound uterine medical treatment of a female patient comprising the steps of:

a) obtaining an end effector having an ultrasound medical-treatment transducer assembly;

b) inserting the end effector into the patient;

c) guiding the end effector within the patient to a region of patient tissue containing the uterus;

d) identifying a blood vessel in the region which supplies blood to a portion of the uterus; and

e) medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood from the blood vessel to the portion of the uterus.

2. The method of claim 1, wherein step d) identifies the blood vessel from ultrasound imaging using the transducer assembly.

3. The method of claim 2, wherein the blood vessel includes blood containing an ultrasound contrast agent.

4. The method of claim 1, wherein the portion of the uterus includes a uterine fibroid, and wherein the blood vessel is a uterine artery, or a branch thereof, which supplies blood to the uterine fibroid.

5. The method of claim 4, also including the step of medically treating the uterine fibroid with ultrasound from the transducer assembly to ablate at least a part of the uterine fibroid.

6. The method of claim 5, also including the step of identifying the uterine fibroid at least in part from ultrasound imaging using the transducer assembly.

7. The method of claim 6, wherein the uterine fibroid includes blood containing an ultrasound contrast agent.

8. The method of claim 1, wherein the portion of the uterus includes a source of abnormal uterine bleeding, and wherein the blood vessel is a uterine artery, or a branch thereof, which supplies blood to the source of abnormal uterine bleeding.

9. The method of claim 8, wherein the source is a uterine fibroid.

10. The method of claim 1, wherein the end effector is an open-surgery end effector.

11. The method of claim 1, wherein the end effector is an endoscopic end effector.

12. The method of claim 11, wherein step c) guides the endoscopic end effector into the uterine cavity.

13. The method of claim 12, wherein the endoscopic end effector is an articulated end effector.

14. The method of claim 13, wherein the endoscopic end effector has a longitudinal axis, has at least two transversely-outwardly-facing ultrasound transducers each having at least one ultrasound transducer element, and has a longitudinally-facing ultrasonic tip transducer.

15. The method of claim 1, wherein the end effector is a laparoscopic end effector.

16. The method of claim 15, wherein the laparoscopic end effector comprises a tissue-retaining device including a first tissue-retaining member having an ultrasound medical-treatment transducer and including a second tissue-retaining member, and wherein step e) includes retaining the blood vessel between the first and second tissue-retaining members.

17. The method of claim 16, wherein the second tissue-retaining member includes an ultrasound reflector.

18. The method of claim 1, wherein the end effector is a catheter end effector, and wherein step c) guides the end effector inside the blood vessel.

19. The method of claim 1, wherein the end effector is a needle end effector.

20. A method for ultrasound uterine medical treatment of a female patient comprising the steps of:

a) obtaining an end effector having an ultrasound medical-treatment transducer assembly;

b) identifying a blood vessel which supplies blood to a portion of the uterus of the patient; and

c) medically treating the blood vessel with ultrasound from the transducer assembly to substantially seal the blood vessel to substantially stop the supply of blood from the blood vessel to the portion of the uterus.

21. The method of claim 20, wherein the end effector is an extracorporeal end effector.

22. The method of claim 21, wherein step b) identifies the blood vessel from ultrasound imaging using the transducer assembly.

23. The method of claim 22, wherein the blood vessel includes blood containing an ultrasound contrast agent.

24. A method for ultrasound uterine medical treatment of a female patient comprising the steps of:

a) obtaining an end effector having an ultrasound medical-treatment transducer assembly;

b) transvaginal-endoscopically inserting the end effector into the patient;

c) guiding the end effector within the patient into the uterine cavity;

d) identifying the endometrium lining of the uterine cavity; and

e) medically treating the endometrium lining with ultrasound from the transducer assembly to ablate a desired thickness of at least a portion of the endometrium lining to substantially stop abnormal uterine bleeding from the endometrium lining.

25. The method of claim 24, wherein the end effector is an articulated end effector.

26. The method of claim 25, wherein the end effector has a longitudinal axis, has at least two transversely-outwardly-facing ultrasound transducers each having at least one ultrasound transducer element, and has a longitudinally-facing ultrasonic tip transducer.

27. The method of claim 24, wherein step d) identifies the endometrium lining of the uterine cavity from ultrasound imaging using the transducer assembly.

28. The method of claim 27, wherein the endometrium lining includes blood containing an ultrasound contrast agent.